Quick Answer
PALISADE BIO, INC. reported Cash And Cash Equivalents At Carrying Value of $133.39 million for the year ending 2025.
- PALISADE BIO, INC. showed an increase of +1,258.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from PALISADE BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2011: $2.35 million | Q1 2012: $5.14 million | Q2 2012: $2.54 million | Q3 2012: $9.87 million | Q1 2013: $12.66 million | Q2 2013: $11.17 million | Q3 2013: $16.40 million | Q1 2014: $18.34 million | Q2 2014: $15.23 million | Q3 2014: $11.95 million | Q1 2015: $13.59 million | Q2 2015: $8.65 million | Q3 2015: $13.13 million | Q1 2016: $7.62 million | Q2 2016: $11.13 million | Q3 2016: $5.68 million | Q1 2017: $11.68 million | Q2 2017: $6.44 million | Q3 2017: $9.06 million | Q1 2018: $9.72 million | Q2 2018: $7.09 million | Q3 2018: $5.74 million | Q4 2018: $5.79 million | Q1 2019: $4.01 million | Q2 2019: $2.28 million | Q3 2019: $7.30 million | Q1 2020: $10.03 million | Q2 2020: $1.52 million | Q3 2020: $751.0 thousand | Q1 2021: $615.0 thousand | Q2 2021: $12.65 million | Q3 2021: $14.10 million | Q1 2022: $6.64 million | Q2 2022: $4.98 million | Q3 2022: $13.99 million | Q1 2023: $13.30 million | Q2 2023: $16.40 million | Q3 2023: $15.31 million | Q1 2024: $11.28 million | Q2 2024: $11.35 million | Q3 2024: $8.04 million | Q1 2025: $7.23 million | Q2 2025: $5.42 million | Q3 2025: $5.23 million.
- Over the full 18 years of available data (2008 to 2025), PALISADE BIO, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 2,620.3%.
- Historical annual values: Fiscal year 2025: $133.39 million | Fiscal year 2024: $9.82 million | Fiscal year 2023: $12.43 million | Fiscal year 2022: $12.38 million | Fiscal year 2021: $10.50 million | Fiscal year 2020: $713.0 thousand | Fiscal year 2019: $5.11 million | Fiscal year 2018: $5.79 million | Fiscal year 2017: $6.67 million | Fiscal year 2016: $15.19 million | Fiscal year 2015: $4.72 million | Fiscal year 2014: $12.52 million | Fiscal year 2013: $16.85 million | Fiscal year 2012: $7.44 million | Fiscal year 2011: $2.35 million | Fiscal year 2010: $9.26 million | Fiscal year 2009: $2.31 million | Fiscal year 2008: $4.90 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: